Growth Hormone Use in Childhood and Adult Cardiovascular Disease—Reply

In Reply We have with great interest read the letter by Malozowski and Lightbourne about our study on long-term cardiovascular morbidity in patients previously treated with childhood growth hormone (GH) and would, first of all, like to thank the authors for having taken interest in our study. However, we would also like to clarify some misconceptions. Malozowski and Lightbourne state as critical limitations that we have failed to account for short stature, information about height by sex, and other hormonal deficiencies. We disagree with this description because we have indeed taken these issues into account.